These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 12102440)
41. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials. WAVE Investigators Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284 [TBL] [Abstract][Full Text] [Related]
43. Peripheral arterial disease: current perspectives and new trends in management. Aslam F; Haque A; Foody J; Lee LV South Med J; 2009 Nov; 102(11):1141-9. PubMed ID: 19864983 [TBL] [Abstract][Full Text] [Related]
44. Use of antiplatelets and lipid lowering therapy in patients with peripheral vascular disease undergoing surgery [corrected]. Aldawood AS; Jaeschke R Saudi Med J; 2002 May; 23(5):585-8. PubMed ID: 12070587 [TBL] [Abstract][Full Text] [Related]
50. A new paradigm: the vascular center. Whittemore A Semin Vasc Surg; 1997 Jun; 10(2):93-7. PubMed ID: 9203260 [TBL] [Abstract][Full Text] [Related]
51. Peripheral arterial disease--towards extended awareness and improved prevention of ischaemic events. Cardiovasc J S Afr; 2004; 15(3):150-1. PubMed ID: 15356909 [No Abstract] [Full Text] [Related]
52. Process of care and outcomes in peripheral arterial disease. Collins TC; Beyth RJ Am J Med Sci; 2003 Mar; 325(3):125-34. PubMed ID: 12640288 [TBL] [Abstract][Full Text] [Related]
53. Atherometric system. A suitable methodology to characterize atherosclerotic lesions in any artery or group of patients. Fernández-Britto JE; Carlevaro PV Zentralbl Pathol; 1991; 137(4):337-40. PubMed ID: 1768684 [TBL] [Abstract][Full Text] [Related]
54. [Diagnosis of sclerotic arterial diseases of the lower limbs]. Guilmot JL; Diot E; Boissier C; Capron L Rev Prat; 1995 Jan; 45(1):38-43. PubMed ID: 7725007 [TBL] [Abstract][Full Text] [Related]
55. The effect of risk factor changes on peripheral arterial disease and cardiovascular risk. Mohler ER Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):259-63. PubMed ID: 15379618 [TBL] [Abstract][Full Text] [Related]
56. [Peripheric artery diseases. Systemic character of atherothrombosis needs a systemic approach to therapy]. Kandykin VV Klin Khir; 2000 Oct; (10):55-9. PubMed ID: 11247439 [No Abstract] [Full Text] [Related]
57. Clinical evaluation and options for infrainguinal atherosclerosis therapy: when to intervene? Jaff MR J Interv Cardiol; 2001 Oct; 14(5):529-32. PubMed ID: 12053644 [TBL] [Abstract][Full Text] [Related]
58. Ten tips for making strides against peripheral artery disease. Harv Heart Lett; 2001 Dec; 12(4):5-6. PubMed ID: 11751080 [No Abstract] [Full Text] [Related]